Palisade Bio receives Nasdaq bid price deficiency notice; 180 days to regain compliance

PALISADE BIO, INC.

Nasdaq notified on May 20, 2022 that PALI common stock closed below $1.00 minimum for 30 consecutive trading days.
Company has 180 calendar days to regain compliance; stock continues trading under symbol PALI.
Compliance achieved if closing bid price is $1.00 or more for at least 10 consecutive business days.
If deficient at end of period, additional 180 days may be available if other listing standards are met.
Company will monitor bid price and may consider options to cure deficiency.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.